acebutolol and folic acid

acebutolol has been researched along with folic acid in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (11.11)	29.6817
2010's	3 (33.33)	24.3611
2020's	2 (22.22)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Baldwin, RL; Wallnöfer, P	1
Asp, NG; Berchtold, P; Dahlqvist, A; Gustafson, A	1
Herman, RH; Herman, YF; Rosensweig, NS; Stifel, FB	1
Falk, V; Hegemann, I; Hofmann, A; Kaserer, A; Maisano, F; Schoenrath, F; Seifert, B; Spahn, DR; Spahn, GH; Stein, P; Theusinger, OM	1
Abdulla, S; Asilia, P; Daubenberger, C; Glass, TR; Issa, A; Kuemmerle, A; Lweno, O; Meyer-Monard, S; Mswata, S; Mwebi, KD; Schmidlin, S; Simon, B; Tanner, M; Vanobberghen, F	1
Karimi, S; Namazi, H	1

Reviews

1 review(s) available for acebutolol and folic acid

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for acebutolol and folic acid

Article	Year
Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet (London, England), 2019, 06-01, Volume: 393, Issue:10187 Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Folic Acid; Heart Diseases; Humans; Male; Maltose; Middle Aged; Preoperative Care; Prospective Studies; Time Factors; Vitamin B 12	2019
Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial. The Lancet. Global health, 2021, Volume: 9, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Folic Acid; Hemoglobins; Humans; Iron; Maltose; Postnatal Care; Postpartum Period; Pregnancy; Tanzania; Treatment Outcome; Young Adult	2021

Article

Year

Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.

Lancet (London, England), 2019, 06-01, Volume: 393, Issue:10187

Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Folic Acid; Heart Diseases; Humans; Male; Maltose; Middle Aged; Preoperative Care; Prospective Studies; Time Factors; Vitamin B 12

2019

Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.

The Lancet. Global health, 2021, Volume: 9, Issue:2

Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Folic Acid; Hemoglobins; Humans; Iron; Maltose; Postnatal Care; Postpartum Period; Pregnancy; Tanzania; Treatment Outcome; Young Adult

2021

Other Studies

6 other study(ies) available for acebutolol and folic acid

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
[On the influence of different nutrient media on the activity of several enzymes in Streptococcus bovis 2281]. Die Naturwissenschaften, 1966, Volume: 53, Issue:24 Topics: Asparagine; Aspartate Aminotransferases; Biotin; Culture Media; Disaccharides; Folic Acid; Fructose-Bisphosphate Aldolase; Glucose; Glutamate Dehydrogenase; Glutamates; Glycoside Hydrolases; Hexokinase; L-Lactate Dehydrogenase; Malate Dehydrogenase; Maltose; Niacinamide; Pantothenic Acid; Phosphotransferases; Pyridines; Riboflavin; Streptococcus; Thiamine	1966
Effects of a biguanide (Metformin) on vitamin B 12 and folic acid absorption and intestinal enzyme activities. Scandinavian journal of gastroenterology, 1971, Volume: 6, Issue:8 Topics: Adult; Biopsy; Enzyme Activation; Female; Folic Acid; Galactosidases; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Maltose; Metformin; Middle Aged; Sucrase; Trehalase; Vitamin B 12	1971
Regulation of human jejunal glycolytic enzymes by oral folic acid. The Journal of clinical investigation, 1969, Volume: 48, Issue:11 Topics: Adult; Diet; Fasting; Folic Acid; Fructose; Fructose-Bisphosphate Aldolase; Glucokinase; Glycoside Hydrolases; Hexokinase; Humans; Injections, Intramuscular; Jejunum; Kinetics; Lactose; Male; Maltose; Obesity; Phosphotransferases; Sucrase; Tetracycline; Vitamin B 12	1969
Fabrication of biocompatible magnetic maltose/MIL-88 metal-organic frameworks decorated with folic acid-chitosan for targeted and pH-responsive controlled release of doxorubicin. International journal of pharmaceutics, 2023, Mar-05, Volume: 634 Topics: Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Hydrogen-Ion Concentration; Magnetic Phenomena; Maltose; Metal-Organic Frameworks	2023